The Rise of AI-Enhanced Diagnostics
Artificial Intelligence is rapidly becoming the backbone of liver health monitoring. One of the most prominent Non-Alcoholic Steatohepatitis Biomarkers Market trends is the use of machine learning to analyze imaging data from FibroScan and MRI-PDFF. By combining these images with traditional blood-based biomarkers, AI models can now predict a patient's risk of progressing to liver failure with...
0 Комментарии 0 Поделились 233 Просмотры 0 предпросмотр